BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

813 related articles for article (PubMed ID: 19808267)

  • 1. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
    Klein L; Massie BM; Leimberger JD; O'Connor CM; Piña IL; Adams KF; Califf RM; Gheorghiade M;
    Circ Heart Fail; 2008 May; 1(1):25-33. PubMed ID: 19808267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study.
    Klein L; O'Connor CM; Leimberger JD; Gattis-Stough W; Piña IL; Felker GM; Adams KF; Califf RM; Gheorghiade M;
    Circulation; 2005 May; 111(19):2454-60. PubMed ID: 15867182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study.
    Filippatos G; Rossi J; Lloyd-Jones DM; Stough WG; Ouyang J; Shin DD; O'connor C; Adams KF; Orlandi C; Gheorghiade M
    J Card Fail; 2007 Jun; 13(5):360-4. PubMed ID: 17602982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
    Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum urea nitrogen, creatinine, and estimators of renal function: mortality in older patients with cardiovascular disease.
    Smith GL; Shlipak MG; Havranek EP; Foody JM; Masoudi FA; Rathore SS; Krumholz HM
    Arch Intern Med; 2006 May; 166(10):1134-42. PubMed ID: 16717177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of prognostic significance of amino-terminal pro-brain natriuretic Peptide versus blood urea nitrogen for predicting events in patients hospitalized for heart failure.
    Shenkman HJ; Zareba W; Bisognano JD
    Am J Cardiol; 2007 Apr; 99(8):1143-5. PubMed ID: 17437744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC
    Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum blood urea nitrogen and long-term mortality in acute ST-elevation myocardial infarction.
    Aronson D; Hammerman H; Beyar R; Yalonetsky S; Kapeliovich M; Markiewicz W; Goldberg A
    Int J Cardiol; 2008 Jul; 127(3):380-5. PubMed ID: 17765341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worsening renal function in children hospitalized with decompensated heart failure: evidence for a pediatric cardiorenal syndrome?
    Price JF; Mott AR; Dickerson HA; Jefferies JL; Nelson DP; Chang AC; O'Brian Smith E; Towbin JA; Dreyer WJ; Denfield SW; Goldstein SL
    Pediatr Crit Care Med; 2008 May; 9(3):279-84. PubMed ID: 18446113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial.
    Blair JE; Pang PS; Schrier RW; Metra M; Traver B; Cook T; Campia U; Ambrosy A; Burnett JC; Grinfeld L; Maggioni AP; Swedberg K; Udelson JE; Zannad F; Konstam MA; Gheorghiade M;
    Eur Heart J; 2011 Oct; 32(20):2563-72. PubMed ID: 21785107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial.
    Rossi J; Bayram M; Udelson JE; Lloyd-Jones D; Adams KF; Oconnor CM; Stough WG; Ouyang J; Shin DD; Orlandi C; Gheorghiade M
    Acute Card Care; 2007; 9(2):82-6. PubMed ID: 17573581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.
    Hillege HL; Nitsch D; Pfeffer MA; Swedberg K; McMurray JJ; Yusuf S; Granger CB; Michelson EL; Ostergren J; Cornel JH; de Zeeuw D; Pocock S; van Veldhuisen DJ;
    Circulation; 2006 Feb; 113(5):671-8. PubMed ID: 16461840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated glomerular filtration rate is an independent predictor for mortality of patients with acute heart failure.
    Takagi A; Iwama Y; Yamada A; Aihara K; Daida H
    J Cardiol; 2010 May; 55(3):317-21. PubMed ID: 20350524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of medicare beneficiaries with worsening renal function during hospitalization for heart failure.
    Kociol RD; Greiner MA; Hammill BG; Phatak H; Fonarow GC; Curtis LH; Hernandez AF
    Am J Cardiol; 2010 Jun; 105(12):1786-93. PubMed ID: 20538131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiorenal interactions: insights from the ESCAPE trial.
    Nohria A; Hasselblad V; Stebbins A; Pauly DF; Fonarow GC; Shah M; Yancy CW; Califf RM; Stevenson LW; Hill JA
    J Am Coll Cardiol; 2008 Apr; 51(13):1268-74. PubMed ID: 18371557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure.
    Aronson D; Mittleman MA; Burger AJ
    Am J Med; 2004 Apr; 116(7):466-73. PubMed ID: 15047036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between worsening renal function and mortality in heart failure patients treated with nesiritide.
    Miller WL; Kurien S; Warfield KT; Wood CM; Jaffe AS
    Int J Cardiol; 2008 May; 126(2):234-9. PubMed ID: 17482692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure?
    Smith GL; Vaccarino V; Kosiborod M; Lichtman JH; Cheng S; Watnick SG; Krumholz HM
    J Card Fail; 2003 Feb; 9(1):13-25. PubMed ID: 12612868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.